Compare PCVX & WFRD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PCVX | WFRD |
|---|---|---|
| Founded | 2013 | 1941 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Metal Fabrications |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.0B | 4.1B |
| IPO Year | 2020 | N/A |
| Metric | PCVX | WFRD |
|---|---|---|
| Price | $46.57 | $76.39 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 7 | 9 |
| Target Price | ★ $101.67 | $85.67 |
| AVG Volume (30 Days) | ★ 1.5M | 699.7K |
| Earning Date | 11-04-2025 | 10-21-2025 |
| Dividend Yield | N/A | ★ 1.31% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 5.52 |
| Revenue | N/A | ★ $4,970,000,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $13.84 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $27.66 | $36.74 |
| 52 Week High | $94.60 | $86.64 |
| Indicator | PCVX | WFRD |
|---|---|---|
| Relative Strength Index (RSI) | 51.97 | 59.41 |
| Support Level | $43.78 | $73.55 |
| Resistance Level | $48.11 | $78.04 |
| Average True Range (ATR) | 1.99 | 2.83 |
| MACD | -0.49 | 0.21 |
| Stochastic Oscillator | 42.99 | 82.72 |
Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.
Weatherford International provides diversified oilfield services across international markets for an array of oilfield types. The firm is a global market leader in artificial lift and tubular running services. Other key product lines include cementing products, directional drilling, and wireline evaluation.